COVID-19 drug Paxlovid may interact with common heart disease drugs
Heart disease patients with COVID-19 are often treated with nirmatrelvir-ritonavir (Paxlovid) to prevent progression to severe disease.
However, the COVID-19 drug can interact with some...
“Bad” cholesterol may increase your risk of long COVID
Cholesterol is a waxy, fat-like substance that your body needs for good health, but in the right amounts. Unhealthy levels of cholesterol can cause...
Over 40% of Americans misled others about having COVID-19 and use of precautions
In a study from the University of Utah, scientists found four of 10 Americans surveyed reported that they were often less than truthful about...
Scientists find how COVID-19 affects the colon
In a study from MedUni Vienna, scientists analyzed the manifestations of COVID-19 in the lungs and colon and pinpointed the differences at a molecular...
A healthy microbiome builds a strong immune system that could help defeat COVID-19
You may not know it, but you have an army of microbes living inside of you that is essential for fighting off threats, including...
Why and when to get a bivalent COVID-19 booster
The original COVID-19 boosters did a great job of preventing severe illness and hospitalization, even during the delta surge.
Then came omicron and its subvariants,...
Third vaccine dose provides longer protection against COVID-19
In a study from the University of Tartu, scientists found that after the third vaccination, the antibody count in the body persists at a...
Monoclonal antibodies remain effective fight omicron variants
In a study from the Francis Crick Institute and elsewhere, scientists found monoclonal antibody therapies continue to neutralize SARS-CoV-2 variants currently in circulation, including...
Mouthwashes may suppress COVID-19 virus
In a study from Hokkaido University, scientists found commercial mouthwashes may help suppress the COVID-19 virus.
SARS-CoV-2, the virus that causes COVID-19, is an airborne...
Oral antiviral drugs could reduce COVID-19 death risk by more than 50%
In a study from The University of Hong Kong, scientists conducted one of the first real-world studies to explore the inpatient use of oral...